Trump may send US troops to neutralize Iran's highly enriched uranium. There are no good options

About 400 kg of Iran's uranium enriched to 60%—enough for roughly 10 crude weapons—may be inaccessible or dispersed after Israel's June 13 attack and a 10-day window before US B-2 strikes; the US dropped 14 bunker-busters but vaults 80–90m deep at Fordow/Natanz may have been reinforced or emptied. Isfahan is now believed to hold much of the HEU (estimated 30–60 cylinders), prompting consideration of a high-risk ground seizure versus on-site destruction, each carrying criticality, toxic contamination, and severe operational hazards. Expect risk-off market moves: upside pressure on oil and defense contractors and elevated regional sovereign and operational risk until the material's status is clarified.

Analysis

Persistent strategic ambiguity about a hostile state's remaining fissile inventory creates a multi-year procurement and risk-insurance premium that does not show up in headline defense budgets overnight. Expect procurement authorities to prioritize three discrete buckets — persistent wide-area ISR and IAEA-style verification services, CBRN mitigation and remediation capabilities, and expeditionary heavy-lift/engineering assets — shifting 5–10% of new program dollars into those lines over the next 12–24 months as programs are re-scoped and awards accelerated.

Market-risk is front-loaded: days-to-weeks for volatility spikes tied to new intelligence releases or botched recovery attempts, 3–12 months for contract announcements and order flows, and 1–3 years for structural changes in force posture and export-control regimes. Two asymmetric tail risks matter: a failed ground recovery with chemical/radiological dispersal (sharp downside for regional asset prices, insurers, and logistics) and a credible, verifiable IAEA accounting (which would quickly compress the “uncertainty premium” across defense, energy and insurance sectors).

Consensus is leaning long broad defense primes; the smarter asymmetric trade is concentrated exposure to CBRN/remote-access engineering and dedicated ISR analytics — smaller-cap suppliers and systems integrators who can scale quickly. If verification tidbits arrive within 60–90 days, expect a rapid mean-reversion of defense multiple expansion of 10–20%, so size and timing of entry are key: buy optionality into the niche winners rather than full-sized multi-billion dollar prime exposure at current risk levels.

Key Decisions for Investors

• Long Northrop Grumman (NOC) 6–12 month call spread (buy 1x near-the-money, sell 1x+ out-of-the-money). Rationale: Backs ISR and strike-platform demand; risk = option premium, reward = 15–30% equity-equivalent if procurement acceleration sustains. Size: 2–4% of tactical book; trim on +20% move.
• Long Leidos (LDOS) or Jacobs Engineering (J) equity (3–12 months). Rationale: Direct exposure to CBRN, remediation, and IAEA-style technical support contracts. Risk/reward: asymmetric — limited downside vs outsized upside if U.S./Allies award urgent technical-assistance contracts; position size 1.5–3% each.
• Commodity/energy hedge: buy short-dated XOM or XLE calls (3–6 months) sized to cover portfolio oil-price exposure. Rationale: Regional hostilities risk could produce 5–15% crude spikes in the near term; options cap downside and provide leverage. Take profits on >25% premium appreciation.
• Relative-value pair: long NOC + LDOS vs short JETS ETF (air travel) for 3 months. Rationale: Defense/CBRN equities should outperform consumer travel if uncertainty persists. Size: small, market-neutral net exposure (~1–2% gross each leg); stop-loss if travel demand data normalizes within 30 days.
• Risk control: allocate no more than 8–10% aggregate to these geopolitics trades; use volatility stops and event hedges (buy protection around major IAEA/verification announcements). Rationale: outcomes are binary and information-driven — avoid full carry into major intelligence/campaign milestones.